Showing results (2181-2190 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 11, 2002
Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30Srinivasu Poondru, Ralph E Parchment, Vivek Purohit, et al.
Investigational New Drugs|August 2, 2003
Toxicity patterns of cytotoxic drugsEtienne Chatelut, Jean-Pierre Delord, Pierre Canal
Investigational New Drugs|April 9, 2001
Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignanciesR R Streiff, J F Bender
Investigational New Drugs|April 9, 2001
Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinomaW S Kim, M M Kim, H J Choi, et al.
Investigational New Drugs|April 9, 2001
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapyJ E Dowell, D H Johnson, J S Rogers, et al.
Investigational New Drugs|September 20, 2001
In vitro activity of liposomal N4octadecyl-1-beta-D-arabinofuranosylcytosine (NOAC), a new lipophilic derivative of 1-beta-D-arabinofuranocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cellsR A Schwendener, K Friedl, H Depenbrock, et al.
Investigational New Drugs|September 20, 2001
Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cellsK Fukuoka, J Usuda, Y Iwamoto, et al.
Investigational New Drugs|September 20, 2001
Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trialR T Zon, J McClean, D Helman, et al.
Investigational New Drugs|September 20, 2001
N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trialL Rajdev, Z F Yu, S Wadler, et al.
Investigational New Drugs|September 20, 2001
Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devicesB Nuijen, M Bouma, C Manada, et al.
Pageof 372